Back to Agenda
Session 1: Different Perspectives on Unmet Medical Need
Session Chair(s)
Claudine Sapède, PharmD
Director, Global HTA Policy
NOVARTIS INTERNATIONAL, Switzerland
Speaker(s)
A Patient’s Perspective
François Houyez
European Organisation for Rare Diseases (EURORDIS), France
Treatment Information and Access Director, Health Policy Advisor
A Regulator’s Perspective
Michael Berntgen, PhD
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
An HTA Body’s Perspective
Antje Behring, PharmD, PhD
Federal Joint Committee (G-BA), Germany
Head, Early Benefit Assessment, Pharmaceuticals Department
Have an account?